Analysts Estimate MacroGenics (MGNX) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 02/29/24
MacroGenics Announces Date of Fourth Quarter 2023 Financial Results Conference CallGlobeNewsWire • 02/27/24
MacroGenics: Evaluating Its Buy Status After A 200% Surge On Prostate Cancer ProspectsSeeking Alpha • 02/20/24
MacroGenics (MGNX) Surges 6.8%: Is This an Indication of Further Gains?Zacks Investment Research • 02/02/24
MacroGenics Provides Update on Corporate Progress and Third Quarter 2023 Financial ResultsGlobeNewsWire • 11/06/23
MacroGenics Announces Date of Third Quarter 2023 Financial Results Conference CallGlobeNewsWire • 10/31/23
MacroGenics Provides Update on Corporate Progress and Second Quarter 2023 Financial ResultsGlobeNewsWire • 08/09/23
MacroGenics Announces Date of Second Quarter 2023 Financial Results Conference CallGlobeNewsWire • 07/31/23
MacroGenics Provides Update on Corporate Progress and First Quarter 2023 Financial ResultsGlobeNewsWire • 05/09/23
MacroGenics Announces Date of First Quarter 2023 Financial Results Conference CallGlobeNewsWire • 05/04/23
MacroGenics (MGNX) to Report Q1 Results: Wall Street Expects Earnings GrowthZacks Investment Research • 04/25/23
MacroGenics Earns $15 Million Milestone Following U.S. FDA Approval of ZYNYZ™ (retifanlimab-dlwr)GlobeNewsWire • 03/22/23